Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Santarus has announced that its licensor, the University of Missouri, has received a notice of allowance from the US Patent and Trademark Office for US patent application, covering methods for treating acid-caused gastrointestinal disorders by administering a solid pharmaceutical composition comprising non-enteric coated omeprazole and certain antacids.
Subscribe to our email newsletter
Subject to final issuance by the US Patent and Trademark Office, the newly allowed claims will have a July 2016 expiration date.
Gerald Proehl, president and CEO of Santarus, said: “We are pleased to receive this notice of allowance and believe that the allowed patent claims, when issued, will further enhance the intellectual property coverage for our immediate-release Zegerid (omeprazole/sodium bicarbonate) capsules and powder for oral suspension products.”